Information on Cancer Treatment Results at Medical Institutions and Information on Excellent Doctors

Worldwide, the number of cancer patients and deaths from cancer has been on the rise in recent years.

February 1, 2024 (London Reuters) The International Agency for Research on Cancer (IARC) under the World Health Organization (WHO) estimated on February 1 that there will be 20 million new cancer cases and 9.7 million deaths worldwide in 2022. The report also highlighted the disparity in treatment between developed and developing countries, estimating that 20 million new cancer cases and 9.7 million deaths will occur in the world in 2022. The report also highlighted the disparity in treatment between developed and developing countries.

Based on data from 185 countries on 36 types of cancer, IARC found that about one in five people will develop cancer in their lifetime, and one in nine men and one in 12 women will die from the disease. However, the risk associated with cancer varies depending on where the patient lives. For example, in developed countries, one in 12 women will develop breast cancer, but only one in 71 will die.

In countries with relatively low "human development index," a measure of standard of living, one in 27 women will be diagnosed with breast cancer, but only one in 48 will die because the population tends to be younger, overweight, etc. IARC officials say that women in these countries are less likely to be diagnosed, and that the delay in diagnosis as well as the lack of quality treatment are the main reasons why women in these countries are less likely to die from breast cancer. In addition, women in these countries are at higher risk of dying from breast cancer due to a lower likelihood of being diagnosed, delayed diagnosis, and inadequate access to quality treatment. Lifestyle changes have also led to an increase in the number of different types of cancer. Colorectal cancer is the third most common among new patients and the second most common cause of death.

The largest number of new cases is lung cancer, the leading cause of death, with 2.5 million new cases diagnosed and 1.8 million deaths each year. 35 million new cases worldwide are expected by 50 years, a 77% increase, according to IARC, due to population growth and aging. But the impact will be uneven: in poor countries, new cases will increase by 142% and mortality rates will double.

　In our business dealings with foreign countries, we hear that Japanese medical institutions and Japanese physicians are highly regarded in other countries. The reasons for this seem to be that Japanese medical personnel are highly regarded for their good patient care, high awareness of cleanliness, diligence in their work, and high standard of medical care. For this reason, we have received offers from many clients from many countries to invite Japanese medical personnel to Japan.

　We would be very happy if you, our overseas clients, would take a look at the information about the cancer treatment results and excellent doctors at Japanese medical institutions and understand the quality of Japanese medical institutions and the excellence of excellent doctors.

We would be honored if you would take the opportunity to come to Japan for treatment, even if it is a very long way from here.

　We will continue to do our best to provide you with the latest information as much as possible.

Agent Professional Inc.
Representative Director Tomoyuki Mifune